Found: 24
Select item for more details and to access through your institution.
Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 12, p. 5569, doi. 10.1111/dom.15906
- By:
- Publication type:
- Article
Cover Image, Volume 19, Issue 12.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 12, p. i, doi. 10.1111/dom.13146
- By:
- Publication type:
- Article
Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 12, p. 1698, doi. 10.1111/dom.12999
- By:
- Publication type:
- Article
Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes.
- Published in:
- Clinical Diabetes, 2021, v. 39, n. 1, p. 72, doi. 10.2337/cd20-0022
- By:
- Publication type:
- Article
Genomic analysis of methanogenic archaea reveals a shift towards energy conservation.
- Published in:
- BMC Genomics, 2017, v. 18, n. 1, p. 1, doi. 10.1186/s12864-017-4036-4
- By:
- Publication type:
- Article
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers.
- Published in:
- Pediatric Diabetes, 2023, p. N.PAG, doi. 10.1155/2023/8867625
- By:
- Publication type:
- Article
Improvements in Glycemic Outcomes in 4738 Children, Adolescents, and Adults with Type 1 Diabetes Initiating a Tubeless Insulin Management System.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 3, p. 593, doi. 10.1007/s13300-023-01366-9
- By:
- Publication type:
- Article
Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy.
- Published in:
- Diabetes Care, 2023, v. 46, n. 4, p. 742, doi. 10.2337/dc22-1915
- By:
- Publication type:
- Article
Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A<sub>1c</sub> and Hypoglycemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096-1102.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Response to comment on Doyle et al. Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care 2014;37:1191-1197.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms.
- Published in:
- Diabetes Care, 2014, v. 37, n. 5, p. 1191, doi. 10.2337/dc13-2108
- By:
- Publication type:
- Article
71-OR: Youth with Type 1 Diabetes and Their Parents Report Improved Quality of Life with the Omnipod 5 Automated Insulin Delivery System.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-71-OR
- By:
- Publication type:
- Article
709-P: Improved Satisfaction and Perceived Usability with the Omnipod 5 Automated Insulin Delivery System Compared with Prior Therapy.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-709-P
- By:
- Publication type:
- Article
704-P: Adults with Type 1 Diabetes Report Improved Quality of Life with the Omnipod 5 Automated Insulin Delivery System.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-704-P
- By:
- Publication type:
- Article
702-P: Glycemic Improvement in 5,094 Pediatric Patients with Type 1 Diabetes (T1D) Using the Omnipod Insulin Management System over First 90 Days of Use.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-702-P
- By:
- Publication type:
- Article
698-P: Glycemic Improvement in 11,273 Adults with Type 1 Diabetes (T1D) Using the Omnipod Insulin Management System over First 90 Days of Use.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-698-P
- By:
- Publication type:
- Article
1296-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Children Aged 2-12 Years without Increasing Risk of Hypoglycemia.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1296-P
- By:
- Publication type:
- Article
995-P: Real-World Insulin Delivery Patterns for 1,202 Adults with Type 2 Diabetes Using the Omnipod Insulin Management System with Cloud-Based Data Management.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-995-P
- By:
- Publication type:
- Article
992-P: Patient-Reported Outcomes for 2,335 Adults with Type 2 Diabetes Using the Omnipod Insulin Management System Show Glycemic Improvement over First 90 Days of Use.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-992-P
- By:
- Publication type:
- Article
978-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Adults and Adolescents without Increasing Risk of Hypoglycemia.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-978-P
- By:
- Publication type:
- Article
215-OR: Safety and Performance of the Omnipod Hybrid Closed-Loop System in Young Children Aged 2-6 Years with Type 1 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-215-OR
- By:
- Publication type:
- Article
Glucose Sensing in the Peritoneal Space Offers Faster Kinetics Than Sensing in the Subcutaneous Space.
- Published in:
- Diabetes, 2014, v. 63, n. 7, p. 2498, doi. 10.2337/db13-1649
- By:
- Publication type:
- Article